scholarly journals Computed Tomography-Guided Percutaneous Cryoablation for ‎ Subcardiac Hepatocellular Carcinoma: Safety, Efficacy, Therapeutic Results and Risk Factors for Survival Outcomes

2020 ◽  
Vol Volume 12 ◽  
pp. 3333-3342
Author(s):  
Chunhou Qi ◽  
Hongfei Gao ◽  
Qinghua Zhao ◽  
Lei Zhang
2013 ◽  
Vol 52 (14) ◽  
pp. 1553-1559 ◽  
Author(s):  
Yasuyuki Tomiyama ◽  
Kazuyuki Takenaka ◽  
Takahiro Kodama ◽  
Miwa Kawanaka ◽  
Kyo Sasaki ◽  
...  

2021 ◽  
Vol 9 ◽  
pp. 2050313X2110524
Author(s):  
Abid M Sadiq ◽  
Minael G Mjemmas ◽  
Adnan M Sadiq ◽  
Gilbert Z Nkya

Sarcomatoid hepatocellular carcinoma is a rare primary malignant liver cancer. The pathogenesis is unclear; however, the risk factors may be similar to that of conventional hepatocellular carcinoma. We present an 18-year-old female who was admitted due to generalized tonic–clonic convulsions. On examination, we palpated a large non-tender mass in the right upper quadrant. An abdominal computed tomography identified it as hepatocellular carcinoma, and spindle-shaped cells were seen on histopathology. She was counseled on her prognosis but opted for local herbal medications rather than chemotherapy, but unfortunately passed away. We present a rare subtype of hepatocellular carcinoma in a young female which is commonly seen in males above the age of 50 years, and despite its grade and stage, overall survival is poor.


Biology ◽  
2021 ◽  
Vol 10 (5) ◽  
pp. 446
Author(s):  
Byung-Gon Na ◽  
Seong-Hoon Kim ◽  
Sang-Jae Park

Background: Living-donor liver transplantation (LDLT) for hepatocellular carcinoma (HCC) has been used as a curative treatment option for hepatocellular carcinoma (HCC) because of a shortage of deceased donors. This study aimed to investigate survival outcomes after LDLT for HCC. Method: This study included 359 patients undergoing LDLT for HCC. We analyzed overall survival (OS) and recurrence-free survival (RFS) and the prognostic factors related to them. Results: The 5-year OS and RFS rates of patients within the Milan criteria (WM) were better than those of patients beyond the Milan criteria (BM) (87.3% vs. 64.1% and 87.6% vs. 57.8%, respectively, both p < 0.05). Alpha-fetoprotein level (AFP) > 400 ng/mL (hazard ratio (HR), 2.07; 95% CI, 1.28–3.36; p < 0.05) and HCC of BM (HR, 2.61; 95% CI, 1.60–4.26; p < 0.05) at immediate pretransplant were independent risk factors of OS. AFP > 400 ng/mL (HR, 2.16; 95% CI, 1.34–3.49; p < 0.05) and HCC of BM (HR, 3.01; 95% CI, 1.81–5.01; p < 0.05) were also independent risk factors of RFS. In pathologic findings of explanted liver, tumor size, Edmondson–Steiner grade III–IV, and microvascular invasion were independent risk factors of both OS and RFS (p < 0.05). Conclusions: BM and AFP > 400 ng/mL at immediate pretransplant are unfavorable predictors of survival outcomes after LDLT for HCC.


2005 ◽  
Vol 201 (5) ◽  
pp. 663-670 ◽  
Author(s):  
Eric Dupont-Bierre ◽  
Philippe Compagnon ◽  
Jean-Luc Raoul ◽  
Gabriel Fayet ◽  
Anne-Sophie de Lajarte-Thirouard ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document